Use of pulmonary function tests in the diagnosis and management of asthma

Clinical Pulmonary Medicine

Volumn 6, Issue 4, 1999, Pages 211-217

  Teeter, John G ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

Airway obstruction; Asthma; Peak expiratory flow; Pulmonary function; Spirometry

Indexed keywords

ALGORITHM; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HUMAN; PEAK EXPIRATORY FLOW; PROVOCATION TEST; SPIROMETRY;

EID: 0032813288     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-199907000-00001     Document Type: Article

References (68)

1. National Asthma Education Program. Expert panel report: guidelines for the diagnosis and management of asthma. Bethesda, MD, US Department of Health and Human Services, 1991. NIH publication No. 91-3042.
2. International consensus report on diagnosis and treatment of asthma. Bethesda, MD. US Department of Health and Human Services, 1992. NIH publication No. 92-3091.
3. National Asthma Education Program. Expert panel report, II: guidelines for the diagnosis and management of asthma. Bethesda, MD. US Department of Health and Human Services, 1997. NIH publication No. 97-4051.
4. Wolle JM, Cwi J. Physicians' prevention-related practice behaviors in treating adult patients with asthma: results of a national survey. J Asthma 1995;32:309-18.
5. Fried RA, Miller RS, Green LA, Sherrod P, Nutting PA. The use of objective measures of asthma severity in primary care: a report from ASPN. J Fam Pract 1995;41:139-43.
6. Hollerman DR Jr, Simel DL. Does the clinical examination predict airflow limitation? JAMA 1995;273:313-9.
7. Shim CS, Williams MH. Relationship of wheezing to the severity of obstruction in asthma. Arch Intern Med 1983;143:890-2.
8. Baumann UA, Haerdi E, Keller R. Relations between clinical signs and lung function in bronchial asthma: how is acute bronchial obstruction reflected in dyspnoea and wheezing? Respiration 1986;50:294-300.
9. Russell NJ, Crichton NJ, Emerson PA, Morgan AD. Quantitative assessment of the value of spirometry. Thorax 1986;41:360-3.
10. Teeter JG, Bleecker ER. Relationship between airway obstruction and respiratory symptoms in adult asthmatics. Chest 1998;113:272-7.
11. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
12. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-36.
13. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-S120.
14. Quackenboss JJ, Lebowitz MD, Krzyzanowski M. The normal range of diurnal changes in peak expiratory flow rates. Am Rev Respir Dis 1991;143:323-30.
15. Ryan G, Latimer KM, Dolovitch J, Hargreave FE. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax 1982;37:423-9.
16. Timonen KL, Nielsen J, Schwartz J, et al. Chronic respiratory symptoms, skin test results, and lung function as predictors of peak flow variability. Am J Respir Crit Care Med 1997;156:776-82.
17. Brand PLP, Postma DS, Kerstjens HAM, Koeter GH, and the Dutch CNSLD study group. Relationship of airway hyperresponsiveness to respiratory symptoms and diurnal peak flow variation in patients with obstructive lung disease. Am Rev Respir Dis 1991;143: 916-21.
18. Enright PL, Sherrill DL, Lebowitz MD. Ambulatory monitoring of peak expiratory flow: reproducibility and quality control. Chest 1995; 107:657-61.
19. Bellia V, Visconti A, Insalaco G, Cuttitta G, Ferrara G, Bonsignore G. Validation of morning dip of peak expiratory flow as an indicator of the severity of nocturnal asthma. Chest 1988;94:108-10.
20. Boushey HA, Holtzman MJ, Sheller JR, Nadel JA. Bronchial hyperreactivity. Am Rev Respir Dis 1980;121:389-413.
21. Cockroft DW, Hargreave FE. Airway hyperresponsiveness. Relevance of random population data to clinical usefulness. Am Rev Respir Dis 1990;142:497-500.
22. Pratter MR, Irwin RS. The clinical value of pharmacologic bronchoprovocation challenge. Chest 1984;85:260-5.
23. Britton J, Tattersfield AE. Does measurement of bronchial hyperreactivity help in the clinical diagnosis of asthma? Eur J Respir Dis 1986;68: 233-8.
24. Hopp RJ, Bewtra AK, Nair NM, Townley RG. Specificity and sensitivity of methacholine inhalation challenge in normal and asthmatic children. J Allergy Clin Immunol 1984;74: 154-8.
25. Deal EC Jr, McFadden ER Jr, Ingram RH Jr, Bresskub FJ, Jaeger JJ. Airway responsiveness to cold air and hyperpnea in normal subjects and in those with hay fever and asthma. Am Rev Respir Dis 1980;121:621-8.
26. Juniper EF, Frith PA, Hargreave FE. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 1981;36:575-9.
27. Cockroft DW, Berscheid BA, Murdock KY. Unimodal distribution of bronchial responsiveness to inhaled histamine in a random human population. Chest 1983;83:751-4.
28. Ruppel G. Manual of pulmonary function testing. St. Louis: Mosby-Year Book, Inc., 1994.
29. Patemore PK, Asher MI, Harrison AC, et al. The interrelationship among bronchial hyperresponsiveness, the diagnosis of asthma and asthma symptoms. Am Rev Respir Dis 1990; 142:549-54.
30. Sears MR, Jones D, Holdaway MD, et al. Prevalence of bronchial reactivity to inhaled methacholine in New Zealand children. Thorax 1986;41:283-9.
31. Nicolai T, Mutius EV, Reitmeir P, Wjst M. Reactivity to cold-air hyperventilation in normal and in asthmatic children in a survey of 5,697 schoolchildren in southern Bavaria. Am Rev Respir Dis 1993;147:565-72.
32. Backer V, Groth S, Dirksen A, et al. Sensitivity and specificity of the histamine challenge test for the diagnosis of asthma in an unselected sample of children and adolescents. Eur Respir J 1991;4:1093-100.
33. Verma EH, Cockcroft DW, Dosman JA. Airway responsiveness to inhaled histamine in chronic obstructive airways disease. Chest 1988;94:457-61.
34. Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:1802-11.
35. Casale TB, Rhodes BJ, Donnelly AL, Weiler JM. Airway responses to methacholine in asymptomatic nonatopic cigarette smokers. J Appl Physiol 1987;62:1888-92.
36. Gerrard JW, Cockcroft DW, Mink JT, Cotton DJ, Poonawala R, Dosman JA. Increased non-specific bronchial reactivity in cigarette smokers with normal lung function. Am Rev Respir Dis 1980;122:577-81.
37. Varpela E, Laitinen LA, Keskinen H, Korhola O. Asthma, allergy, and bronchial hyperreactivity to histamine in patients with bronchiectasis. Clin Allergy 1978;8:273-80.
38. Mitchell I, Corey M, Woenne R, Krastins IR, Levison H. Bronchial hyperreactivity in cystic fibrosis and asthma. J Pediatr 1978;93:744-8.
39. Betchel JJ, Starr T, Dantzker DR, Bower JS. Airway hyperreactivity in patients with sarcoidosis. Am Rev Respir Dis 1981;124:759-61.
40. Monkare S. Clinical aspects of farmer's lung: airway reactivity, treatment and prognosis. Eur J Respir Dis Suppl 1984;137:1-68.
41. Chhabra SK, Gaur SN. Airway hyperreactivity in tropical pulmonary eosinophilia. Chest 1988;93:1105-6.
42. Sasaki F, Ishizaki T, Mifune J, Fujimura M, Nishioka S, Miyabo S. Bronchial hyperresponsiveness in patients with chronic congestive heart failure. Chest 1990;97:534-8.
43. Snashall PD, Chung KF. Airway obstruction and bronchial hyperresponsiveness in left ventricular failure and mitral stenosis. Am Rev Respir Dis 1991;144:945-56.
44. Ramsdale EH, Morris MM, Roberts RS, Hargreave FE. Asymptomatic bronchial hyperresponsivenss in rhinitis. J Allergy Clin Immunol 1985;75:573-7.
45. Muller BA, Leick CA, Smith RM, Suelzer MT, Richardson HB. Comparisons of specific and non-specific bronchoprovocation in subjects with asthma, rhinitis, and healthy subjects. J Allergy Clin Immunol 1993;91:758-72.
46. Barker AF, Hirshman CA, D'Silva R, Hanifin JM. Airway responsiveness in atopic dermatitis. J Allergy Clin Immunol 1991;87:780-3.
47. Stanescu DC, Frans A. Bronchial asthma without increased airway reactivity. Eur J Respir Dis 1982;63:5-12.
48. Giffon E, Orehek D, Vervloet D, Arnaud A, Charpin J. Asthma without airway hyperresponsiveness to carbachol. Eur J Respir Dis 1987;70:229-33.
49. Irwin RS, Widdicombe J. Cough. In: Murray JH, Nadel JA, editors. Textbook of respiratory medicine. Vol. 1. Philadelphia: W.B. Saunders Co., 1994:529-44.
50. Sly PD, Cahill P, Willet K, Burton P. Accuracy of mini peak flow meters in indicating changes in lung function in children with asthma. BMJ 1994;308:572-4.
51. Sly PD. Peak expiratory flow monitoring in pediatric asthma: is there a role? J Asthma 1996;33:277-87.
52. Chmelik F, Doughty A. Objective measurements of compliance in asthma treatment. Ann Allergy 1994;73:527-32.
53. Quirce S, Contreras G, Dybuncioi A, Chan-Yeung M. Peak expiratory flow monitoring is not a reliable method for establishing the diagnosis of occupational asthma. Am J Respir Crit Care Med 1995;152:1100-2.
54. Reeder KP, Dolce JJ, Duke L, Raczynski JM, Bailey WC. Peak flow meters: are they monitoring tools or training devices? J Asthma 1990;27:219-27.
55. Mendoza GR, Sander N, Scherrer D. A user's guide to peak flow monitoring. Fairfax, VA: Mothers of Asthmatics, Inc., 1988.
56. Gibson PG, Wlodarczyk J, Hensley MJ, Muree-Allen K, Olson LG, Saltos N. Using quality-control analysis of peak expiratory flow recordings to guide therapy for asthma. Ann Intern Med 1995;123:488-92.
57. Connolly CK, Prescott RJ, Alcock SM, Gatnash AA. Actual over best function as an outcome measure in asthma. Respir Med 1994;88:453-9.
58. Janson-Bjerklie S, Shnell S. Effect of peak flow information on patterns of self-care in adult asthma. Heart Lung 1988;17:543-9.
59. Beasley R, Cushley M, Holgate ST. A self management plan in the treatment of adult asthma. Thorax 1989;44:200-4.
60. Charlton I, Charlton G, Broomfield J, Mullee MA. Evaluation of peak flow and symptoms only self management plans for control of asthma in general practice. BMJ 1990;301: 1355-9.
61. Malo JL, L'Archeveque J, Trudeau C, d'Aquino C, Cartier A. Should we monitor peak expiratory flow rates or record symptoms with a simple diary in the management of asthma? J Allergy Clin Immunol 1993;91: 702-9.
62. Drummond N, Abdalla M, Beattie JAG, Buckingham JK, Lindsay T, Osman LM. Effectiveness of routine self monitoring of peak flow in patients with asthma. BMJ 1994;308:564-7.
63. Ignacio-Garcia JM, Gonzalez-Santos P. Asthma self management education program by home monitoring of peak expiratory flow. Am J Respir Crit Care Med 1995;151:353-9.
64. Lahdensuo A, Haahtela T, Herrala J, et al. Randomized comparison of guided self management and traditional treatment of asthma over one year. BMJ 1996;312:748-52.
65. Chan-Yeung M, Chang JH, Manfreda J, Ferguson A, Becker A. Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma. Am J Respir Crit Care Med 1996;154:889-93.
66. Cowie RL, Revitt SG, Underwood MF, Field SK. The effect of a peak-flow based action plan in the prevention of exacerbations of asthma. Chest 1997;112:1534-8.
67. Horvath I, Donnelly LE, Kiss A, et al. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med 1998;158:1042-6.
68. Gibson PG. Use of induced sputum to examine airway inflammation in childhood asthma. J Allergy Clin Immunol 1998;102:S100-S101.